Worth reading
74In focus
Scored from 4 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
-31
Operating profit year on year (%)Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationSecond quarter of the fiscal year ending March 20277 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥30,172 million-0.7%
Operating profit¥2,178 million-31.0%
Ordinary income¥2,273 million-31.7%
Net income¥1,666 million-2.2%
Selling, general and administrative expenses¥11,749 million
Gross Profit Margin
Rate46.2%
Year on year against the same period last year+1.1 percentage points
Operating profit margin
Rate7.2%
Year on year against the same period last year-3.2 percentage points
Full-year earnings forecast
Net Sales
¥70,000 million
Operating profit
¥8,000 million
Ordinary income
¥8,200 million
Profit attributable to owners of the parent
¥5,500 million
Earnings per share
¥200.82
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales107.8%
Operating profit272.4%
Ordinary income303.2%
Interim net profit attributable to owners of the parent416.5%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Both revenue and operating profit exceeded the forecast for the six months ended the second quarterAssumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
- Assumed exchange rate (U.S. dollar)¥150
- Assumed exchange rate (Russian ruble)¥1.9
New initiatives
- ホロン is conducting research and development on photomask defect repair technology using aberration-corrected SEM
- Developing photomask defect repair equipment
Key KPIsA metric the company considers important as a management benchmark.
- Order backlog of the semiconductor-related business¥8,473 millionYear on year against the same period last year+40.3%
- Order backlog of the measurement and metrology equipment business¥6,398 millionYear on year against the same period last year-6.9%
- Order backlog of the medical and healthcare equipment business¥460 millionYear on year against the same period last year+58.1%
Segment results
Semiconductor-related business
Net Sales
¥1,279 million-74.8%
Operating profit
¥-675 million
Order backlog
¥8,473 million+40.3%
Measurement and metrology equipment business
Net Sales
¥14,925 million+10.5%
Operating profit
¥1,027 million+51.3%
Order backlog
¥6,398 million-6.9%
Medical and healthcare equipment business
Net Sales
¥13,967 million+18.4%
Operating profit
¥2,909 million+70.5%
Order backlog
¥460 million+58.1%
Orders received and order backlog
Semiconductor-related business¥8,473 million
Measurement and metrology equipment business¥6,398 million
Medical and healthcare equipment business¥460 million
Annual Dividend
Annual¥60 /share
Interim¥30 /share
End of period¥30 /share
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥30,172 million (YoY -0.7%) |
| Operating profit | ¥2,178 million (YoY -31.0%) |
| Ordinary income | ¥2,273 million (YoY -31.7%) |
| Net income | ¥1,666 million (YoY -2.2%) |
| Gross Profit Margin | Rate 46.2% / Year on year against the same period last year +1.1 percentage points |
| Operating profit margin | Rate 7.2% / Year on year against the same period last year -3.2 percentage points |
| Selling, general and administrative expenses | ¥11,749 million |
| Full-year earnings forecast | Net Sales ¥70,000 million / Operating profit ¥8,000 million / Ordinary income ¥8,200 million / Profit attributable to owners of the parent ¥5,500 million / Earnings per share ¥200.82 |
| Progress against full-year forecast | Net Sales 107.8% / Operating profit 272.4% / Ordinary income 303.2% / Interim net profit attributable to owners of the parent 416.5% |
| Self-assessment against the plan | Both revenue and operating profit exceeded the forecast for the six months ended the second quarter |
| Segment results | Semiconductor-related business Net Sales ¥1,279 million (YoY -74.8%) / Operating profit ¥-675 million / Order backlog ¥8,473 million (YoY +40.3%) / Measurement and metrology equipment business Net Sales ¥14,925 million (YoY +10.5%) / Operating profit ¥1,027 million (YoY +51.3%) / Order backlog ¥6,398 million (YoY -6.9%) / Medical and healthcare equipment business Net Sales ¥13,967 million (YoY +18.4%) / Operating profit ¥2,909 million (YoY +70.5%) / Order backlog ¥460 million (YoY +58.1%) |
| Key KPIs | Indicator name Order backlog of the semiconductor-related business / Value ¥8,473 million / Year on year against the same period last year +40.3%, Indicator name Order backlog of the measurement and metrology equipment business / Value ¥6,398 million / Year on year against the same period last year -6.9%, Indicator name Order backlog of the medical and healthcare equipment business / Value ¥460 million / Year on year against the same period last year +58.1% |
| Assumptions Underlying the Business Outlook | Item Assumed exchange rate (U.S. dollar) / Value ¥150, Item Assumed exchange rate (Russian ruble) / Value ¥1.9 |
| Annual Dividend | Annual ¥60 /share / Interim ¥30 /share / End of period ¥30 /share |
| Orders received and order backlog | Semiconductor-related business ¥8,473 million / Measurement and metrology equipment business ¥6,398 million / Medical and healthcare equipment business ¥460 million |
| New initiatives | ホロン is conducting research and development on photomask defect repair technology using aberration-corrected SEM, Developing photomask defect repair equipment |
Items this document does not state (13)
Results for the three months of the current quarterBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsPayout ratioAcquisition of treasury sharesCapital expendituresMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Demand adjustments continued in the semiconductor-related business, resulting in lower profit as the decline in revenue prevented the absorption of fixed costs. Meanwhile, the strong performance of the measurement and metrology equipment business and the medical and healthcare equipment business, refunds of US tariffs, and foreign exchange effects caused results for the six months ended the second quarter to exceed the initial forecast, so the full-year forecast was revised upward.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.